Allelic Loss Involving the Tumor Suppressor Genes APC and MCC and Expression of the APC Protein in the Development of Dysplasia and Carcinoma in Barrett Esophagus

This publication has 16 references indexed in Scilit:

• Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma.
  Journal of Clinical Pathology, 1997
• 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus.
  Proceedings of the National Academy of Sciences, 1996
• Mutations in the APC gene and their implications for protein structure and function
  Current Opinion in Genetics & Development, 1995
• Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group.
  Gut, 1994
• Aberrations of tumor‐suppressor genes (p53, apc, mcc and Rb) in esophageal squamous‐cell carcinoma
  International Journal of Cancer, 1994
• Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer
  The American Journal of Surgery, 1994
• Primary Gastric Carcinoma Cells Frequently Lose Heterozygosity at theAPCandMCCGenetic Loci
  Japanese Journal of Cancer Research, 1993
• Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers.
  Proceedings of the National Academy of Sciences, 1992
• Identification of a Gene Located at Chromosome 5q21 that Is Mutated in Colorectal Cancers
  Science, 1991
• Observer variation in the diagnosis of dysplasia in Barrett's esophagus
  Human Pathology, 1988